Serotonin Labs India Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 12-12-2024
- Paid Up Capital ₹ 0.10 M
as on 12-12-2024
- Company Age 9 Year, 3 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.84 Cr
as on 12-12-2024
- Revenue %
(FY 2020)
- Profit -14.15%
(FY 2020)
- Ebitda -12.58%
(FY 2020)
- Net Worth -70.44%
(FY 2020)
- Total Assets 52.33%
(FY 2020)
About Serotonin Labs India
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.84 Cr.
Rajesh Reddy, Shefali Sabharanjak, and Vijitha Reddy serve as directors at the Company.
- CIN/LLPIN
U72200KA2015FTC084841
- Company No.
084841
- Company Classification
Private Limited Foreign Company Incorporated In India
- Incorporation Date
21 Dec 2015
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Serotonin Labs India?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vijitha Reddy  | Director | 09-Oct-2018 | Current |
| Shefali Sabharanjak | Director | 20-Aug-2019 | Current |
| Rajesh Reddy | Director | 21-Dec-2015 | Current |
Financial Performance of Serotonin Labs India.
Serotonin Labs India Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 14.15% decrease in profit. The company's net worth observed a substantial decline by a decrease of 70.44%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Serotonin Labs India?
In 2020, Serotonin Labs India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Atma Investments And Resources Private LimitedActive 22 years 11 months
Rajesh Reddy is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 19 Feb 2024 | ₹4.20 M | Open |
Others Creation Date: 15 Dec 2023 | ₹5.00 M | Open |
Others Creation Date: 29 Nov 2023 | ₹5.00 M | Open |
How Many Employees Work at Serotonin Labs India?
Unlock and access historical data on people associated with Serotonin Labs India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Serotonin Labs India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Serotonin Labs India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
